Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MECLIZINE HYDROCHLORIDE, with a corresponding US DMF Number 25418.
Remarkably, this DMF maintains an Active status since its submission on October 25, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2015, and payment made on September 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II